[Chronic hepatitis C in HIV-infected patients receiving highly active antiretroviral therapy (HAART)].
Introduction of HAART in the treatment of HIV-infection revealed, that clinical consequences of HIV-infection in these patients occur earlier than in HIV-negative ones. It may be a reason of unsuccessfully antiretroviral therapy. Another problem is hepatotoxicity of antiretroviral therapy, especially in HCV-infected patients. In the follow, treatment of chronic hepatitis C seems to be justified.
Halota
Waldemar
W
Katedra i Klinika Chorób Zakaznych, Akademii Medycznej im. L. Rydygiera w Bydgoszczy.
Pawłowska
Małgorzata
M
D017088:AIDS-Related Opportunistic Infections / Q000188:drug therapy*; D023241:Antiretroviral Therapy, Highly Active / Q000009:adverse effects*; D015658:HIV Infections / Q000150:complications / Q000188:drug therapy*; D019698:Hepatitis C, Chronic / Q000150:complications* / Q000188:drug therapy*; D006801:Humans; D008099:Liver / Q000187:drug effects*; D012307:Risk Factors; D013997:Time Factors